NanoString Blog
Category: Q&A
GeoMx DSP Q&A
nCounterユーザーインタビュー
順天堂大学医学部 人体病理病態学 准教授 齋藤剛 先生に、がん個別化医療を目指したご研究やnCounter®でのimbalance解析を用いた融合遺伝子スクリーニングについて伺いました。
GeoMx DSP Q&A Services and Core Labs Spatial Biology Spatial Transcriptomics
Spatial Transcriptomic Services: Azenta Life Sciences Paves the Way.
Azenta Life Sciences, formerly known as GENEWIZ, has been serving the academic and biopharma markets with its comprehensive next-generation sequencing services (NGS) since 1999. Their extensive website of Services makes…
Data Analysis GeoMx DSP GeoScript Hub Q&A
The Inspiration Behind GeoScript™ Hub for Spatial Data Analysis
Meet two of NanoString’s finest, Debra Toburen, Senior Director of Software Product Management, and Prajan Divakar, Senior Product Enablement Scientist, who are focused on enabling customers to get the most…
Grants nCounter Q&A
NanoString People of Color and Allies (nPOCA) ERG Grant Support Program
2020 will be remembered as the year that a novel viral pandemic and the protests galvanized by the death of George Floyd disrupted modern society. These events, while seemingly unrelated,…
Neuroscience Q&A
Meet the New Brainiacs in the Fight Against Neurological Diseases
The Liddelow Lab is part of the Neuroscience Institute at NYU Langone. The lab’s research focus is astrocytes and their involvement in human neurological diseases. The team discovered that different…
Data Analysis nCounter Q&A
Gene Expression and Data Analysis Tools: A Cali Core Facility’s Story
ROSALIND is a cloud-based gene expression and genomic data analysis tool designed for life scientists. In October 2020, NanoString® Technologies and ROSALIND announced a partnership to grant global access to…
Oncology Q&A
What is the Next Frontier in Cellular Therapy?
In early June 2021, NanoString and the Parker Institute for Cancer Immunotherapy (PICI) announced a multi-center collaboration to characterize 800 CAR-T samples in a unique and concerted effort to understand…
Clinical Research nCounter Q&A Services and Core Labs
How a Molecular Diagnostics Company is Changing Cancer Research
Molecular diagnostics, or molecular pathology, refers to a range of tests and high-throughput methods analyzing the genome to detect, diagnose, and treat diseases. The ultimate goal is to achieve personalized…
Oncology Q&A
A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering
NanoString has an unparalleled and longstanding tradition of developing best-in-class cancer research tools, thanks to an extensive knowledge accumulated in a decade of interrogating all aspects of the disease. Last…
Q&A Services and Core Labs
Vision, Cutting-Edge Technology, and Deep Expertise. Interview with the Scientists at Propath UK, the Royals Among the CROs.
A few years ago, the UK Prime Minister’s office announced that Propath, a trusted specialist in molecular pathology for biopharmaceutical research and development, had been nominated to receive a Queen’s…
Data Analysis nCounter Q&A
Discover the New Platform for Analyzing Gene Expression Profiles
ROSALIND is a cloud-based genomics and gene expression analysis platform. Recently NanoString® has announced its partnership with its provider OnRamp Bioinformatics, to integrate our knowledge and expertise into an optimized…
Q&A Services and Core Labs
Serotonin, Gut-Brain-Microbiome Axis and an Inspired Young Scientist–How a Core Facility is Born: Q&A with Prof. Beate Niesler
Imagine you are setting up for an interview with a prominent professor at the University of Heidelberg in Germany, in which you will focus on how a scientific interest triggered…